Compound 1967
Identifiers
- Canonical SMILES:
CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)C1CCN(CC1)C(=O)C1CCCCC1
- IUPAC name:
N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-1-cyclohexanecarbonyl-N-methylpiperidine-4-carboxamide
- InChi:
InChI=1S/C34H33Cl2F3N4O4/c1-42(32(46)20-9-11-43(12-10-20)33(47)19-5-3-2-4-6-19)18-21-13-23(35)15-26(30(21)44)29-16-24(27(17-40)31(45)41-29)25-14-22(34(37,38)39)7-8-28(25)36/h7-8,13-16,19-20,44H,2-6,9-12,18H2,1H3,(H,41,45)
- InChiKey:
XYNFLQKEZVDXRD-UHFFFAOYSA-N
External links
![]() 44431598 |
![]() CHEMBL234421 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Survivin dimer | 7.00 | cancer | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 688.18 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 5.42 | |||
TPSA | 110.94 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1016/j.bmcl.2007.03.042 | 25c | BIRC5 O15392 |
|
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 7.00 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5561 | 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | DB08705 | |
0.4450 | Losmapimod | DB12270 | |
0.4429 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE | DB07025 | |
0.4310 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 | |
0.4304 | CPI-1205 | DB14581 | |
0.4264 | N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE | DB08031 | |
0.4253 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE | DB07075 | |
0.4240 | Talnetant | DB06429 | |
0.4220 | JPC-3210 | DB15609 | |
0.4163 | Garenoxacin | DB06160 | |
0.4095 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | DB07006 | |
0.4089 | Tazemetostat | DB12887 | |
0.4044 | 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID | DB07265 | |
0.4027 | Topotecan | DB01030 | |
0.3993 | Batefenterol | DB12526 |